6.39
0.29 (4.67%)
| 前收盘价格 | 6.10 |
| 收盘价格 | 6.24 |
| 成交量 | 2,486,548 |
| 平均成交量 (3个月) | 3,447,709 |
| 市值 | 569,179,328 |
| 价格/销量 (P/S) | 8.81 |
| 股市价格/股市净资产 (P/B) | 1.15 |
| 52周波幅 | |
| 利润日期 | 14 Aug 2025 |
| 营业利益率 (TTM) | -111.10% |
| 稀释每股收益 (EPS TTM) | -2.21 |
| 季度收入增长率 (YOY) | 479.00% |
| 总债务/股东权益 (D/E MRQ) | 14.50% |
| 流动比率 (MRQ) | 9.84 |
| 营业现金流 (OCF TTM) | -142.46 M |
| 杠杆自由现金流 (LFCF TTM) | -64.11 M |
| 资产报酬率 (ROA TTM) | -19.35% |
| 股东权益报酬率 (ROE TTM) | -34.26% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 看跌 | 看跌 |
| Biotechnology (全球的) | 看跌 | 看跌 | |
| 股票 | Verve Therapeutics, Inc. | 看涨 | 看跌 |
AIStockmoo 评分
| 分析师共识 | 5.0 |
| 内部交易活动 | NA |
| 价格波动 | -2.0 |
| 技术平均移动指标 | 2.5 |
| 技术振荡指标 | 2.0 |
| 平均 | 1.88 |
|
Verve Therapeutics Inc clinical-stage company developing a new class of genetic medicines for cardiovascular disease, or CVD, with the potential to transform treatment from chronic therapies to single-course gene editing medicines. The current paradigm of chronic care is fragile requiring rigorous patient adherence, extensive healthcare infrastructure, and regular healthcare access, and leaves many patients without adequate care. Its pipelines are PCSK9, ANGPTL3, and LPA. The group has one reportable segment relating to the research and development of gene-editing medicines. The segment derives its current revenues from research and development collaborations. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 投资方式 | Small Core |
| 内部持股比例 | 5.19% |
| 机构持股比例 | 94.62% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Casdin Capital, Llc | 31 Mar 2025 | 3,995,571 |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 39.00 (Canaccord Genuity, 510.81%) | 购买 |
| 中 | 25.00 (291.54%) | |
| 低 | 24.00 (Guggenheim, 275.88%) | 购买 |
| 平均值 | 29.33 (359.36%) | |
| 总计 | 3 购买 | |
| 平均价格@调整类型 | 4.69 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| Canaccord Genuity | 15 Apr 2025 | 39.00 (510.81%) | 购买 | 4.97 |
| Guggenheim | 15 Apr 2025 | 24.00 (275.88%) | 购买 | 4.97 |
| HC Wainwright & Co. | 14 Apr 2025 | 25.00 (291.54%) | 购买 | 4.12 |
| 25 Mar 2025 | 15.00 (134.93%) | 购买 | 5.84 |
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合